Cognitive Enhancement Strategies in Neurodegenerative Disease Management

Neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease and related proteinopathies impose a mounting burden on global health through progressive loss of memory, executive function and activities of daily living. Cognitive enhancement strategies aim to bolster neural resilience, preserve synaptic integrity and slow decline by targeting diverse mechanistic pathways. Pharmacological approaches include administration of neurotrophic factors to augment synaptic plasticity, small-molecule agents to modulate neuroinflammation and neurotransmitter systems, and advanced formulations to improve blood–brain barrier penetration. Non-pharmacological interventions encompass non-invasive brain stimulation, structured physical exercise, dietary modulation and cognitive training, each shown to reinforce cognitive reserve and rehabilitative potential. Current research emphasises multimodal regimens integrating molecular therapies with lifestyle modifications, underpinned by biomarker-driven patient stratification and digital monitoring. Ageing populations worldwide accentuate the urgency of efficacious, accessible interventions capable of delivering sustained cognitive benefits across diverse care settings. Together, these strategies hold promise for delaying onset of dementia, enhancing quality of life and reducing societal costs.

Research from Nature Portfolio

Recent studies have demonstrated the potential of systemic delivery of the longevity-associated factor klotho to enhance cognition in aged mammalian models. Low-dose administration of this factor was found to increase synaptic plasticity in rodents and to improve memory performance in aged nonhuman primates without adverse effects. Mechanistic analyses revealed enhanced dendritic spine density, upregulation of synaptic function markers, and improved neuronal survival in hippocampal circuits. These findings offer proof-of-concept for translation of neurotrophic factor supplementation into therapeutic regimens for age-related cognitive impairment and highlight dose-dependent optimisation as critical for efficacy.

Cognitive Enhancement Strategies in Neurodegenerative Disease Management publication trend

The graph below shows the total number of articles in cognitive enhancement strategies in neurodegenerative disease management across all publications each year (not limited to Nature Index journals).

Technical terms

Synaptic plasticity: The capacity of neuronal synapses to strengthen or weaken over time in response to activity, underlying learning and memory.

Non-invasive brain stimulation: Techniques such as transcranial magnetic stimulation or transcranial direct current stimulation applied externally to modulate neural excitability.

Blood–brain barrier: A selective vascular interface that regulates passage of molecules between the circulatory system and the central nervous system.

Cognitive reserve: The brain’s resilience to pathological damage, influenced by factors such as education, lifestyle and network efficiency.

Mild cognitive impairment (MCI): A clinical condition characterised by noticeable cognitive decline beyond normal ageing yet not severe enough to significantly impair daily functioning.

References

1. Longevity factor klotho enhances cognition in aged nonhuman primates. Nature Aging (2023).
2. Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial). PLOS Medicine (2025).
3. Comparative efficacy of NIBS and Physical Exercise on cognitive function in patients with MCI or AD: a systematic review and meta-analysis. Med-X (2025).
4. Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer’s Disease. Frontiers in Aging Neuroscience (2020).